$1.19
-0.01-0.83%
At close: -
$1.16
-0.03-2.50%
After Hours: 7:31 PM EDT
Companies issue guidance, or expectations of future EPS and revenue, so investors have a sense of how much money a company will make in a future period.
There have been no specific sales or earnings guidance reported for Spero Therapeutics in recent months.
Browse guidance and forecast on all stocks.